1. Home
  2. LPAA vs HRTX Comparison

LPAA vs HRTX Comparison

Compare LPAA & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPAA
  • HRTX
  • Stock Information
  • Founded
  • LPAA 2024
  • HRTX 1983
  • Country
  • LPAA United States
  • HRTX United States
  • Employees
  • LPAA N/A
  • HRTX 122
  • Industry
  • LPAA
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LPAA
  • HRTX Health Care
  • Exchange
  • LPAA Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • LPAA 296.1M
  • HRTX 325.0M
  • IPO Year
  • LPAA 2024
  • HRTX 1987
  • Fundamental
  • Price
  • LPAA $10.31
  • HRTX $2.05
  • Analyst Decision
  • LPAA
  • HRTX Strong Buy
  • Analyst Count
  • LPAA 0
  • HRTX 2
  • Target Price
  • LPAA N/A
  • HRTX $5.50
  • AVG Volume (30 Days)
  • LPAA 36.3K
  • HRTX 1.9M
  • Earning Date
  • LPAA 01-01-0001
  • HRTX 05-06-2025
  • Dividend Yield
  • LPAA N/A
  • HRTX N/A
  • EPS Growth
  • LPAA N/A
  • HRTX N/A
  • EPS
  • LPAA N/A
  • HRTX N/A
  • Revenue
  • LPAA N/A
  • HRTX $148,518,000.00
  • Revenue This Year
  • LPAA N/A
  • HRTX $11.18
  • Revenue Next Year
  • LPAA N/A
  • HRTX $13.15
  • P/E Ratio
  • LPAA $48.01
  • HRTX N/A
  • Revenue Growth
  • LPAA N/A
  • HRTX 12.43
  • 52 Week Low
  • LPAA $9.66
  • HRTX $1.04
  • 52 Week High
  • LPAA $10.70
  • HRTX $3.93
  • Technical
  • Relative Strength Index (RSI)
  • LPAA N/A
  • HRTX 44.82
  • Support Level
  • LPAA N/A
  • HRTX $2.00
  • Resistance Level
  • LPAA N/A
  • HRTX $2.61
  • Average True Range (ATR)
  • LPAA 0.00
  • HRTX 0.18
  • MACD
  • LPAA 0.00
  • HRTX -0.02
  • Stochastic Oscillator
  • LPAA 0.00
  • HRTX 8.20

About LPAA Launch One Acquisition Corp. Class A Ordinary shares

Launch One Acquisition Corp is a blank check company.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: